CME Certificates will be issued digitally after Speaker Evaluations and Overall Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration. Surveys will be available online starting the day of the symposium. You must complete the process by July 21, 2025 in order to receive your certificate. Certificates will be available online until December 31st and are printable directly from the website.
The AAFP has reviewed 31st Annual San Diego Heart Failure Summer Symposium and
deemed it acceptable for up to TBD Live AAFP Prescribed credits. Term of Approval
is from 06/27/2025 to 06/28/2025. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as
equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's
Recognition Award. When applying for the AMA PRA, Prescribed credit earned
must be reported as Prescribed, not as Category 1.
To keep pace with the rapid growth in our understanding of heart failure and, most importantly, to better treat patients with this disease, the 31st Annual San Diego Summer Heart Failure Symposium will provide a comprehensive overview of emerging concepts of heart failure management and new approaches to therapy. The series of didactic presentations, case discussions and Q & A sessions are designed to efficiently deliver new information that will help provide better care to patients and offer expert advice of how to implement new advances into clinical practice.
This year's Symposium will present sessions on The Cardiorenal Liver Metabolic Axis, Advances in Treating HFpEF, PAH and Amyloidosis, Hypertrophic Cardiomyopathy, Managing Patients with Heart Failure, Atrial Fibrillation/Preventing Sudden Cardiac Death/Genetics and Gene Therapy and Catheter Based Interventions, Shock and Management of Advanced Heart Failure. The lectures in these sessions will provide a comprehensive overview of new drugs, devices and strategies for treating patients with heart failure and will describe practical approaches for implementation. Highlights of the Symposium will be the 11th Annual Stanley Lloyd, M.D. Lecture on "Improving the Quality of Care and Outcomes for Heart Failure", 2nd Annual Founders Lecture on “Heart Failure - Looking Back and Looking Forward: A 100 year Perspective" and Featured Talks on The Cardiometabolic-Kidney-Liver and What's New in Cardiac Transplant. Each morning, the Symposium will start with a series of illustrative case vignettes, each one highlighting a different management strategy.
At the conclusion of this activity, participants should be able to:
The target audience for this activity includes cardiologists, internists, primary care physicians, nurses and allied healthcare professionals.
Heart failure (HF) currently affects well over million Americans. Moreover, prevalence is increasing in both developed and developing countries around the world. In the U.S. alone, an estimated 670,000 new cases of heart failure are diagnosed each year. HF adversely affects quality of life and increases hospitalization and mortality rates. It is the leading cause of hospitalization in elderly individuals in the United States. Moreover, within 8 years of diagnosis, 80% of men and 70% of women less than 65 years of age with new onset heart failure will die.
Our understanding of HF is changing rapidly and new treatments that help improve outcomes are available. The Symposium is designed to help clinicians synthesize new information about heart failure and integrate it into effective strategies of care of their patients. The Symposium will provide a comprehensive overview of diagnostic approaches, current evidence-based therapies and treatment strategies as well as emerging approaches for treatment.